Top Markets
Coin of the day
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Rank in Stocks #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Share Price
$0.17616661
Last synced: 2026-08-21
Market Cap
$73.48M
Change (1 day)
0.18%
Change (1 year)
-37.76%
Country
TW
Trade Mercury Biopharmaceutical Corporation (6932)

Category

Stock price history for Mercury Biopharmaceutical Corporation (6932)
Highest end of day price: $0.19 on 2026-08-01

Lowest end of day price: $0.35 on 2022-12-01
Stock price history of Mercury Biopharmaceutical Corporation from 2022 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -18.88%
2025 -28.11%
2024 -33.04%
2023 75.06%
2022 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$163.63 24.47%
DE
$37.61 20.44%
JP
$223.11 32.20%
CH
$20.99 11.67%
IN